Source: – Press Release / Jan 16 2015

CORAL GABLES, FL / ACCESSWIRE / January 16, 2015 / Recreational cannabis, federal government easement on policy, and increase support from the masses has propelled massive industry growth for cannabis companies this year. Investors have found that there have been many opportunities to turn a profit during these very early stages of this industry boom. As the market continues to grow and the hopes of a less risk filled sector arise, investors continue to look for opportunity as more companies join the marijuana revolution. According to MMJ Business Daily, 2015 is expected not only to see more investment dollars flow into the market but it could even outpace the growth rate seen in 2014. The reason? States like Nevada, Illinois, Massachusetts, Oregon, and Alaska have all been identified as industry drivers this year. Furthermore, the rise in “BIG MONEY” from some major investment funds has just started to hit the marijuana sector.

Oxis Inernational Inc (OTC:OXIS) has even attracted the likes of some of the top brass is research for cannabinoids. First the company brought on Dr. Sean Xie, one of the foremost research scientists for CBDs and just yesterday Oxis announce that it would be adding Dr. James Mule to the Scientific Advisory Boar. Dr. Mule is a Special Government Employee of the NCI and the FDA, recognized for his research and clinical contributions to cancer immunotherapy. As a result of these announcements, both volume and price have seen a jump. Wednesday of this week marked the highest volume day the stock has seen this year while price continues to churn between 0.025-0.027. CEO Tony Cataldo has been credited with developing biotech companies into industry leaders. His lasts endeavor with Genesis Biotech, now Lion Biotechnologies started out as a micro-cap company and grew into a company that trades above $8 a share. With his expertise, the company looks to follow a similar path in building a strong, industry-leading organization.

CannaVest Corp (CANV) recently announced that the results of independent testing have proved the safety and quality of its products. In December, CannaVest commenced cooperative efforts with Project CBD to ensure the cannabis/hemp industry and the consuming public is provided with accurate and meaningful information concerning CannaVest Corp.’s CBD offerings. “We are proud of our products, our lab processes and personnel and our commitment to quality, which we believe separates us from others in our industry,” stated Michael Mona, Jr., President and Chief Executive Officer of CannaVest. Mr. Mona continued, “[w]e were pleased to work with Project CBD, and through our collaboration with Project CBD, we are happy to report these test results to the public. We are committed to providing the highest quality products on the market today, and the independent testing results bear this out.”

Since the close of 2014, CannaVest shares have rallied and this most recent announcement has been cause for increased volume in the market. From a price of $2.26 on December 31 to highs yesterday of $3.49, CANV has managed to jump more than $1 per share in the matter of just a few weeks.

Pazoo, Inc. (PZOO) reported that its marijuana testing lab Harris Lee, LLC, is now a 100% wholly owned subsidiary of Pazoo. The company acquired the remaining 45% of Harris Lee in exchange for 450,000 of Pazoo’s Series B Preferred Stock. Since Tuesday, the stock has reversed in price and has moved up by as much as 97%.

“We are very excited about how we are currently positioned in the marijuana testing industry,” stated Pazoo CEO David Cunic. “The combination of MA & Associates, LLC within Nevada, along with Harris Lee, LLC outside Nevada, gives Pazoo the ability to focus solely on providing the most comprehensive testing criterion available, benefiting both growers and dispensaries.”

About is the leading web destination for all things cannabis. Investors can find marijuana related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. DAMJ VENTURES LLC which owns, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

DAMJ VENTURES LLC, which owns, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. DAMJ VENTURES LLC which owns, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Contact Information:
[email protected]